Alkermes plc (NASDAQ:ALKS - Get Free Report) was the target of a large decrease in short interest in...
Mesirow Institutional Investment Management Inc. acquired a new stake in shares of Alkermes plc (NAS...
Alkermes plc (NASDAQ:ALKS - Free Report) - Equities research analysts at Leerink Partnrs reduced the...
Alkermes plc (NASDAQ:ALKS – Get Free Report) has been assigned an average rating of “Moderate Buy” f...
Biopharmaceutical Leader Alkermes Schedules Conference Call for May 1, 2025Related Stocks: ALKS,...